WS-3
CAS No. 1421227-52-2
WS-3 ( WS3 | WS 3 )
产品货号. M11759 CAS No. 1421227-52-2
一种小分子,可诱导 β 细胞增殖,EC50 为 74 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥353 | 有现货 |
|
| 10MG | ¥620 | 有现货 |
|
| 25MG | ¥1163 | 有现货 |
|
| 50MG | ¥1841 | 有现货 |
|
| 100MG | ¥2961 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥497 | 有现货 |
|
生物学信息
-
产品名称WS-3
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种小分子,可诱导 β 细胞增殖,EC50 为 74 nM。
-
产品描述A small molecule that can induce proliferation of β cells with EC50 of 74 nM; modulates the activity of Erb3 binding protein-1 and the IκB kinase pathway; can reversibly proliferates primary RPE cells isolated from fetal and adult human donors.
-
体外实验WS3 induces pancreatic R7T1 β cell proliferation in dose response, with an EC50 value of 0.28 μM.WS3 (1.0 nM-1.0 μM) reversibly proliferate primary retinal pigment epithelial (RPE) cells isolated from fetal and adult human donors. Following withdrawal of WS3, RPE cells differentiate into a functional monolayer, as exhibited by their expression of mature RPE genes and phagocytosis of photoreceptor outer segments.
-
体内实验——
-
同义词WS3 | WS 3
-
通路Immunology/Inflammation
-
靶点IκB kinase (IKK)
-
受体ErbB3-BindingProtein-1(EBP1)|IκBkinase
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number1421227-52-2
-
分子量569.5781
-
分子式C28H30F3N7O3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 43 mg/mL
-
SMILESCN1CCN(CC2=CC=C(NC(NC3=CC=C(OC4=CC(NC(C5CC5)=O)=NC=N4)C=C3)=O)C=C2C(F)(F)F)CC1
-
化学全称Cyclopropanecarboxamide, N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Rosiglitazone HCl
Rosiglitazone (BRL 49653) hydrochloride 是一种具有口服活性的 PPARγ 选择性激动剂 (EC50: 60 nM, Kd: 40 nM)。Rosiglitazone hydrochloride 是一种 TRPC5 激活剂 (EC50: 30 μM) 和 TRPM3 抑制剂。Rosiglitazone hydrochloride 可用于肥胖、糖尿病、衰老、卵巢癌的研究。
-
ACHP
ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β. ACHP has anti-HIV-1 activity and inhibits HIV-1 long terminal repeat (LTR)-driven gene expression through inhibition of NF-κB activation, inhibits TNF-α-induced NF-κB (p65) recruitment to the HIV-1 LTR, and inhibits TNF-α-induced NF-κB (p65) recruitment to the HIV-1 LTR. ACHKP has anti-HIV-1 activity and inhibits TNF-α-induced recruitment of NF-κB (p65) to the HIV-1 LTR.
-
SU-909
SU-909 (SU909, IKKα-IN-48) 是一种有效的选择性 IKKα 抑制剂,Ki 为 0.08±0.07 uM。
021-51111890
购物车()
sales@molnova.cn

